Compare NTAP & STE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTAP | STE |
|---|---|---|
| Founded | 1992 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.2B | 25.9B |
| IPO Year | 1995 | 1992 |
| Metric | NTAP | STE |
|---|---|---|
| Price | $117.21 | $263.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $123.15 | ★ $268.25 |
| AVG Volume (30 Days) | ★ 2.4M | 674.3K |
| Earning Date | 11-25-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.77% | 0.96% |
| EPS Growth | 5.78 | ★ 59.39 |
| EPS | 5.75 | ★ 6.97 |
| Revenue | ★ $6,637,000,000.00 | $5,702,415,000.00 |
| Revenue This Year | $4.95 | $9.24 |
| Revenue Next Year | $4.87 | $6.30 |
| P/E Ratio | ★ $20.40 | $37.72 |
| Revenue Growth | 2.53 | ★ 7.08 |
| 52 Week Low | $71.84 | $200.98 |
| 52 Week High | $131.30 | $268.60 |
| Indicator | NTAP | STE |
|---|---|---|
| Relative Strength Index (RSI) | 59.71 | 59.06 |
| Support Level | $106.52 | $256.68 |
| Resistance Level | $116.54 | $268.60 |
| Average True Range (ATR) | 3.67 | 4.64 |
| MACD | 1.25 | -0.69 |
| Stochastic Oscillator | 96.97 | 65.59 |
NetApp Inc is a provider of enterprise data management and storage solutions. The company's segments include Hybrid Cloud and Public Cloud. It generates maximum revenue from the Hybrid Cloud segment. The Hybrid Cloud segment offers a portfolio of storage management and infrastructure solutions that help customers recast their traditional data centers with the power of the cloud. This portfolio is designed to operate with public clouds to unlock the potential of hybrid, multi-cloud operations. Hybrid Cloud is composed of software, hardware, and related support, as well as professional and other services. Geographically, the company generates the majority of its revenue from the United States, Canada and Latin America (Americas).
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.